On November 4th, I will be running the New York City Marathon, marking the 10-year anniversary of the first one I ran. In 2008 and 2009 I proudly ran for the Samuel Waxman Foundation which I hold near and dear to my heart.
I ran my first two marathons in honor of my late husband Mark Fizulich who passed from Leukemia on March 9, 2008.
This year, I will be running in honor of my Mom, Mary Corcoran. My mom was diagnosed at 57 years young with Alzheimer’s. Prior to getting sick my mother was my biggest supporter and the rock in my life. She exemplified love, grace and beauty in everything she did. My mom is the reason I have my resilience, strength, faith and dedication. Although her battle with Alzheimer’s prohibits her from greeting me at the finish line like she did in years past, I will forever cherish and remember her enormous smile and embrace.
This year as I cross the finish line I am so grateful that my greatest joys: Holly (4), Will (3) and Charley (17 months) will be there to embrace me at the finish line. I am thankful because I see so much of my mom in each one of them and I know her love is always with us.
Thank you for your support and being a part of the fight to find a cure by generously donating to the Samuel Waxman Foundation.
Cancer affects us all, and it is this reality that drives the Samuel Waxman Cancer Research Foundation's (SWCRF) efforts to accelerate scientific breakthroughs that are leading to cures and better treatments. The SWCRF Institute Without Wallspioneered the practice of collaboration among cancer scientists that has built a brain trust of experts across the world's top research institutes.
SWCRF made significant progress in cancer research.
$100 Million- invested in cancer research since the inception of the Samuel Waxman Cancer Research Foundation in 1976
200 Researchers- who represent some of the best scientific minds studying different therapy and epigenetics
03 Continents- including North America, Asia and Europe. Waxman funded investigators are collaborating with each other all over the globe
43 - years of breakthrough research to deliver minimally toxic therapies to patients